Skip to content

Clinical trials

Phase 2 Carcinoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 2 Country / region: Switzerland Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20201
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Active, not recruiting1
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation1
Iovance Biotherapeutics, Inc.1
Novartis Pharmaceuticals1
Pfizer1
Philogen S.p.A.1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma6
Adenocarcinoma2
Basal Cell Carcinoma1
Bronchial Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Digestive System Diseases1
Digestive System Neoplasms1
Head and Neck Neoplasms1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.